CASI Pharmaceuticals
CASI
#10617
Rank
S$5.44 M
Marketcap
S$0.26
Share price
0.00%
Change (1 day)
-89.05%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): S-$3.59

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$3.54. In 2024 the company made an earnings per share (EPS) of S-$3.27 a decrease over its 2023 EPS that were of S-$2.58.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$3.599.88%
2024S-$3.2726.73%
2023S-$2.58-32.89%
2022S-$3.8411.9%
2021S-$3.43-38.44%
2020S-$5.58-8.96%
2019S-$6.1350%
2018S-$4.0877.78%
2017S-$2.305.88%
2016S-$2.17-22.73%
2015S-$2.81-76.09%
2014S-$11.74318.18%
2013S-$2.81-71.79%
2012S-$9.9665.96%
2011S-$6.00-50%
2010S-$12.00-18.97%
2009S-$14.81-63.64%
2008S-$40.723.57%
2007S-$39.32-60.56%
2006S-$99.7097.22%
2005S-$50.55-2.7%
2004S-$51.95-45.59%
2003S-$95.48-61.8%
2002S-$249.94-25.52%
2001S-$335.60-21.38%
2000S-$426.8713.86%
1999S-$374.92149.53%
1998S-$150.2598.15%
1997S-$75.8310.2%
1996S-$68.81